1. Home
  2. SANA vs XPEL Comparison

SANA vs XPEL Comparison

Compare SANA & XPEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sana Biotechnology Inc.

SANA

Sana Biotechnology Inc.

HOLD

Current Price

$3.12

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Logo XPEL Inc.

XPEL

XPEL Inc.

HOLD

Current Price

$44.59

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
SANA
XPEL
Founded
2018
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Industrial Specialties
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.3B
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
SANA
XPEL
Price
$3.12
$44.59
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
1
Target Price
$7.80
$56.00
AVG Volume (30 Days)
3.6M
244.4K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
17.24
12.12
EPS
N/A
0.37
Revenue
N/A
$476,200,000.00
Revenue This Year
N/A
$12.64
Revenue Next Year
N/A
$11.98
P/E Ratio
N/A
$118.30
Revenue Growth
N/A
13.27
52 Week Low
$1.98
$31.26
52 Week High
$6.55
$55.91

Technical Indicators

Market Signals
Indicator
SANA
XPEL
Relative Strength Index (RSI) 42.42 51.67
Support Level $3.03 $32.66
Resistance Level $3.43 $54.81
Average True Range (ATR) 0.20 2.88
MACD -0.03 0.06
Stochastic Oscillator 23.81 37.50

Price Performance

Historical Comparison
SANA
XPEL

About SANA Sana Biotechnology Inc.

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.

About XPEL XPEL Inc.

XPEL Inc is a supplier of protective films, coatings, and related services principally to the automobile aftermarket, new car dealerships, and automobile original equipment manufacturers, or OEMs. The majority of its revenue is derived from Product, which includes Paint protection film and Window film. The company derives revenue from Service, which includes Software, Cutbank credits, and Installation labor. The majority of revenue is derived from the United States.

Share on Social Networks: